283 related articles for article (PubMed ID: 7594656)
1. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model.
Harrison CJ; Britt WJ; Chapman NM; Mullican J; Tracy S
J Infect Dis; 1995 Nov; 172(5):1212-20. PubMed ID: 7594656
[TBL] [Abstract][Full Text] [Related]
2. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
3. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
4. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
[TBL] [Abstract][Full Text] [Related]
5. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
Schleiss MR; Bourne N; Bernstein DI
J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.
Hashimoto K; Yamada S; Katano H; Fukuchi S; Sato Y; Kato M; Yamaguchi T; Moriishi K; Inoue N
Vaccine; 2013 Jun; 31(31):3199-205. PubMed ID: 23684839
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
[TBL] [Abstract][Full Text] [Related]
9. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
Schleiss MR; Stroup G; Pogorzelski K; McGregor A
Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
[TBL] [Abstract][Full Text] [Related]
10. Low maternal CD4 count at inception of gestational cytomegalovirus (CMV) infection and impaired humoral response: effect on congenital CMV infection in the guinea pig.
Harrison CJ; Burger R
Clin Immunol Immunopathol; 1991 Aug; 60(2):171-80. PubMed ID: 1676941
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes.
Schleiss MR; Fernández-Alarcón C; Hernandez-Alvarado N; Wang JB; Geballe AP; McVoy MA
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960639
[TBL] [Abstract][Full Text] [Related]
12. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
[TBL] [Abstract][Full Text] [Related]
13. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
Choi KY; McGregor A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
[TBL] [Abstract][Full Text] [Related]
14. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
Bravo FJ; Cardin RD; Bernstein DI
J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
[TBL] [Abstract][Full Text] [Related]
15. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.
Schleiss MR; Jensen NJ
J Virol Methods; 2003 Mar; 108(1):59-65. PubMed ID: 12565154
[TBL] [Abstract][Full Text] [Related]
17. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against transplacental cytomegalovirus transmission: vaccine reactivation and efficacy in guinea pigs.
Bia FJ; Miller SA; Lucia HL; Griffith BP; Tarsio M; Hsiung GD
J Infect Dis; 1984 Mar; 149(3):355-62. PubMed ID: 6325549
[TBL] [Abstract][Full Text] [Related]
20. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs.
Chatterjee A; Harrison CJ; Britt WJ; Bewtra C
J Infect Dis; 2001 Jun; 183(11):1547-53. PubMed ID: 11343203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
